LCID
Lucid Group, Inc.
LCID has the edge over TRIP overall, supported by stronger fundamentals and stronger modeled upside.
TRIP
Tripadvisor, Inc.
TRIP has slightly lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
TRIP Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
TRIP's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
TRIP PE Valuation
TRIP has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
TRIP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect TRIP's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over TRIP on earnings, with more consistent year-over-year improvement.
TRIP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.61 | — |
| Q3 2026 | -$3.07 | -565% |
| Q2 2026 | $0.02 | -96% |
| Q1 2026 | $0.11 | -72% |
| Q4 2025 | $0.31 | +675% |
| Q3 2025 | $0.66 | +164% |
| Q2 2025 | $0.50 | +194% |
| Q1 2025 | $0.39 | +129% |
| Q4 2024 | $0.04 | -50% |
TRIP has swung to a loss: it lost $3.07 per share over the past year, after a profit the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over TRIP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
TRIP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $436.4M | -21% |
| Q2 2026 | $441.9M | -16% |
| Q1 2026 | $382.4M | -3.9% |
| Q4 2025 | $411M | 0% |
| Q3 2025 | $553M | +3.9% |
| Q2 2025 | $529M | +6.4% |
| Q1 2025 | $398M | +0.8% |
| Q4 2024 | $411M | +5.4% |
TRIP's revenue has slid since its 2025 peak: $436M last quarter, down 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -77% | -90 points |
| Q2 2026 | 8.6% | -2.6 points |
| Q1 2026 | -6.6% | -2.8 points |
| Q4 2025 | -8.3% | -8.3 points |
| Q3 2025 | 13% | -0.5 points |
| Q2 2025 | 11% | +3.9 points |
| Q1 2025 | -3.8% | 0 points |
| Q4 2024 | 0% | -8.2 points |
TRIP has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
TRIP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$136.7M | -647% |
| Q2 2026 | $137.7M | -22% |
| Q1 2026 | $101.3M | +22% |
| Q4 2025 | -$122M | -$96M |
| Q3 2025 | $25M | +$88M |
| Q2 2025 | $177M | +392% |
| Q1 2025 | $83M | -33% |
| Q4 2024 | -$26M | +$9M |
TRIP has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
TRIP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -384K shares |
| 1 year | -5% | -6.2M shares |
| 3 years | -18% | -25.8M shares |
| 5 years | -19% | -27M shares |
| Available history | -16% | -23.2M shares |
TRIP has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $50M |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | $25M |
| Q3 2023 | — |
| Q4 2020 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TRIP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.8x | Very low |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -1.3x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
TRIP has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
TRIP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.1 | Neutral |
| Stochastic | 9.6 | Oversold |
TRIP's weekly RSI is 32 (neutral) and its Stochastic is 10 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
TRIP PE vs Consumer Cyclical Sector
| Metric | TRIP | Sector median | Relative |
|---|---|---|---|
| PE | 461x | 18x | 2,458% above |
| PE % | 96 | 47 | 49 pts above |
TRIP has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
TRIP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.47 | 14% below |
| 20 week MA | $10.4 | 30% below |
| 50 week MA | $11.3 | 36% below |
| 100 week MA | $13.4 | 46% below |
| 200 week MA | $16.0 | 55% below |
TRIP is in a downtrend: it's below all five of its weekly moving averages, and 55% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
TRIP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.3 | $26.0 | -14% |
| 2021 | $26.0 | $27.3 | +4.8% |
| 2022 | $27.3 | $17.9 | -35% |
| 2023 | $17.9 | $21.5 | +21% |
| 2024 | $21.5 | $14.6 | -32% |
| 2025 | $14.6 | $14.1 | -3.2% |
| 2026 YTD | $14.1 | $7.25 | -49% |
TRIP has the edge over LCID on returns for 2026, with the stronger performance.